Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion. Includes gestational age and risk factors for neurotoxicity in the thresholds.

    • Disclaimer

      Disclaimer - BiliTool - Newborn values:

    • BiliTool EMR

      BiliTool EMR | System Status BiliTool EMR allows an...

    • FAQ

      Can I use BiliTool with transcutaneous bilirubin? TcB...

    • Subscribe

      Subscribe - BiliTool - Newborn values:

  2. Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.

  3. www.aap.org › en › patient-careHyperbilirubinemia

    Hyperbilirubinemia Treatment Graphs by Age and Risk Factor. The following graphs show follow-up recommendations by gestational age and presence of neurotoxicity risk factors.

  4. 5 sie 2022 · This committee worked from 2014 to 2022 to review new evidence and to identify opportunities to clarify and improve the 2004 guideline. This report underwent extensive peer review by a wide array of clinicians and experts in neonatal hyperbilirubinemia and by parents of children with kernicterus.

  5. 1 cze 2007 · Hyperbilirubinemia is very common and usually benign in the term newborn infant and the late preterm infant at 35 to 36 completed weeks’ gestation. Critical hyperbilirubinemia is uncommon but has the potential for causing long-term neurological impairment.

  6. 19 maj 2010 · This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.

  7. Bhutani Nomogram When using this nomogram, remember that "risk" refers to the risk of a subsequent bilirubin level in that infant >95th percentile for age. AAP 7-04